Q1 Earnings Forecast for Aspen Aerogels Issued By B. Riley

Aspen Aerogels, Inc. (NYSE:ASPNFree Report) – Equities researchers at B. Riley dropped their Q1 2025 earnings estimates for shares of Aspen Aerogels in a note issued to investors on Wednesday, February 19th. B. Riley analyst R. Pfingst now anticipates that the construction company will post earnings per share of ($0.08) for the quarter, down from their previous estimate of $0.09. B. Riley has a “Buy” rating and a $22.00 price objective on the stock. The consensus estimate for Aspen Aerogels’ current full-year earnings is $0.22 per share. B. Riley also issued estimates for Aspen Aerogels’ Q2 2025 earnings at $0.02 EPS and FY2025 earnings at $0.22 EPS.

Aspen Aerogels (NYSE:ASPNGet Free Report) last issued its earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%.

Several other analysts have also recently commented on ASPN. Canaccord Genuity Group reduced their price objective on shares of Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating for the company in a research note on Friday, February 14th. Barclays reduced their price objective on shares of Aspen Aerogels from $25.00 to $13.00 and set an “overweight” rating for the company in a research note on Wednesday. StockNews.com upgraded shares of Aspen Aerogels to a “sell” rating in a research report on Wednesday. Craig Hallum cut their target price on shares of Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating for the company in a research report on Friday, February 14th. Finally, Seaport Res Ptn cut shares of Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, February 12th. One analyst has rated the stock with a sell rating, one has given a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $22.44.

Check Out Our Latest Report on Aspen Aerogels

Aspen Aerogels Stock Down 1.4 %

Shares of NYSE:ASPN opened at $8.04 on Friday. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. Aspen Aerogels has a fifty-two week low of $7.96 and a fifty-two week high of $33.15. The firm’s 50-day simple moving average is $11.75 and its 200-day simple moving average is $18.15. The company has a market cap of $659.27 million, a price-to-earnings ratio of 50.22 and a beta of 2.14.

Institutional Investors Weigh In On Aspen Aerogels

Several large investors have recently made changes to their positions in ASPN. Sandia Investment Management LP acquired a new stake in shares of Aspen Aerogels in the fourth quarter worth $89,000. AlphaQuest LLC grew its holdings in Aspen Aerogels by 54.0% during the 4th quarter. AlphaQuest LLC now owns 11,395 shares of the construction company’s stock valued at $135,000 after purchasing an additional 3,998 shares in the last quarter. KLP Kapitalforvaltning AS acquired a new stake in Aspen Aerogels during the 4th quarter valued at $164,000. Connors Investor Services Inc. acquired a new stake in Aspen Aerogels during the 4th quarter valued at $168,000. Finally, Journey Strategic Wealth LLC acquired a new stake in Aspen Aerogels during the 4th quarter valued at $178,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

(Get Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Featured Stories

Earnings History and Estimates for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.